medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 3

<< Back Next >>

Acta Med 2017; 15 (3)

Myelofibrosis

Moreno OL, Alarcón SA, Díaz GEJ, Rodríguez WFL
Full text How to cite this article 10.35366/74396

DOI

DOI: 10.35366/74396
URL: https://dx.doi.org/10.35366/74396

Language: Spanish
References: 9
Page: 225-229
PDF size: 381.79 Kb.


Key words:

Bone marrow, biopsy of bone, myelofibrosis, anemia, multidisciplinary care.

ABSTRACT

This is a review about myelofibrosis based on a case that presents to our emergency room, male in the mid-sixties with multiple organic failure, who is studied based on the altered blood tests and image screening by Hematology, Urology and Pneumolgy teams, diagnosing pulmonary adenocarcinoma and myelofibrosis.


REFERENCES

  1. Komrokji RS, Verstovsek S, Padron E, List AF. Advances in the management of myelofibrosis. Cancer Control. 2012; 19 (4 Suppl): 4-15.

  2. Mesa RA, Verstovsek S, Cervantes F, Barosi G, Reilly JT, Dupriez B et al. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leuk Res. 2007; 31 (6): 737-740.

  3. Tefferi A. How I treat myelofibrosis. Blood. 2011; 117 (13): 3494-3504.

  4. Mascarenhas JO, Orazi A, Bhalla KN, Champlin RE, Harrison C, Hoffman R. Advances in myelofibrosis: a clinical case approach. Haematologica. 2013; 98 (10): 1499-1509.

  5. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000; 342 (17): 1255-1265.

  6. Vallespí T, Imbert M, Mecucci C, Preudhomme C, Fenaux P. Diagnosis, classification, and cytogenetics of myelodysplastic syndromes. Haematologica. 1998; 83 (3): 258-275.

  7. Reilly JT, McMullin MF, Beer PA, Butt N, Conneally E, Duncombe A et al. Guideline for the diagnosis and management of myelofibrosis. Br J Haematol. 2012; 158 (4): 453-471.

  8. Thiele J, Kvasnicka HM, Müllauer L, Buxhofer-Ausch V, Gisslinger B, Gisslinger H. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. Blood. 2011; 117 (21): 5710-5718.

  9. Guglielmelli P, Pancrazzi A, Bergamaschi G, Rosti V, Villani L, Antonioli E et al. Anaemia characterizes patients with myelofibrosis harbouring Mpl mutation. Br J Haematol. 2007; 137 (3): 244-247.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2017;15